International Journal of Gerontology (Sep 2018)

Anti-Dementia Drugs and Hepatotoxicity–Report of Two Cases

  • Haruka Hirono,
  • Kazuhiko Watanabe,
  • Katsuhiko Hasegawa,
  • Kazuhiko Hiroyasu,
  • Koichi Shibasaki,
  • Shogo Ohkoshi

Journal volume & issue
Vol. 12, no. 3
pp. 261 – 263

Abstract

Read online

Summary: Two patients with Alzheimer's disease who developed hepatitis caused by anti-dementia drugs are presented. Case 1: An 84-year-old-woman was referred to our hospital with profound jaundice. The levels of liver enzymes and jaundice decreased after the cessation of memantine and yokukansan (herbal medicine approved for dementia in Japan). Case 2: An 82-year-old-man was referred because of elevated transaminases. Liver biopsy showed central necrosis typical for drug-induced liver injury. The levels of transaminases decreased after withdrawal of rivastigmine transdermal patch treatment. Anti-dementia drugs have been safely used in terms of hepatotoxicity. However, some cases might be missed because of the difficulty in recognizing signs and symptoms in elderly and dementia patients. Keywords: drug-induced liver injury, alzheimer's disease, anti-dementia drugs, elderly